Increasing vaccine potency through exosome antigen targeting
- 21 November 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (50), 9361-9367
- https://doi.org/10.1016/j.vaccine.2011.09.133
Abstract
No abstract availableKeywords
Funding Information
- Susan G. Komen (KG080627, BC050221, R01 CA95447, P50 CA89496-01)
- U.S. Department of Defense (KG080627, BC050221, R01 CA95447, P50 CA89496-01)
- National Cancer Institute (KG080627, BC050221, R01 CA95447, P50 CA89496-01)
- National Cancer Institute (KG080627, BC050221, R01 CA95447, P50 CA89496-01)
This publication has 26 references indexed in Scilit:
- Differential Effects of Viral Vectors on Migratory Afferent Lymph Dendritic CellsIn VitroPredict Enhanced ImmunogenicityIn VivoJournal of Virology, 2011
- Exosomes and Cancer: A Newly Described Pathway of Immune SuppressionClinical Cancer Research, 2011
- Harnessing the immune response to treat cancerOncogene, 2010
- An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without OncogenicityClinical Cancer Research, 2010
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15RαPLOS ONE, 2009
- Comparison of multiple vaccine vectors in a single heterologous prime-boost trialVaccine, 2008
- Targeting Tumor Antigens to Secreted Membrane VesiclesIn vivoInduces Efficient Antitumor Immune ResponsesCancer Research, 2008
- Exosomes and the MICA-NKG2D system in cancerBlood Cells, Molecules, and Diseases, 2005
- Cancer vaccines: between the idea and the realityNature Reviews Immunology, 2003